The USPTO cleared a patent filed in November 2023, with a status indicating it has been approved and the patent is expected ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

The issue is ongoing and widespread, frustrating patients and families across the country who rely on certain medications to manage ADHD, narcolepsy and other conditions. Ruane's pharmacy hasn't been ...

Concerta and Vyvanse are both long-acting stimulant medications taken to treat ADHD, but they differ in their formulations and additional uses. Both medications effectively improve focus, attention, ...

While the U.S. Drug Enforcement Administration increased the production limit of stimulant drugs used to treat ADHD, there's still a high demand.

The study included participants taking ADHD drug treatment (56.7%), and the researchers found this was associated with significantly reduced rates of suicidal behaviors, substance misuse, transport ...